Atlas Trials

Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events

Clinical trial NCT05224661 · TERMINATED

Trial details

NCT number
NCT05224661
Sponsor
Center for International Blood and Marrow Transplant Research
Status
TERMINATED
Study type
OBSERVATIONAL
Acute Myeloid Leukemia in Remission
Start date
2022-08-26
Primary completion
2025-12-12
Enrollment
303

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.